The biotech knee implant developer posted revenue of $42,600 in the period. Its adjusted revenue was $43,000. The company's shares closed at 62 ...
News
- Ocugen: 2Q Earnings Snapshot
- The Latest: California heat wave raises coronavirus concerns
The deals with Novavax, an American biotech company, and Janssen, a Belgian company owned by Johnson & Johnson, mean the U.K. has now ...
- Indonesia takes part in late-stage China vaccine trial
... government announced the partnership between state-owned enterprise Bio Farma and the Chinese company Sinovac BioTech in early July.
- Histogen: 2Q Earnings Snapshot
The biotechnology company posted revenue of $108,000 in the period. In the final minutes of trading on Thursday, the company's shares hit $2.68.
- 'We need action now': Sales tax proposal for San Antonio economic recovery now in voters hands
City estimates show Nirenberg's initiative could help 40,000 people get credentials needed for higher-paying jobs in medicine, bioscience, information ...